"Prostatic Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the PROSTATE.
| Descriptor ID |
D011471
|
| MeSH Number(s) |
C04.588.945.440.770 C12.294.260.750 C12.294.565.625 C12.758.409.750
|
| Concept/Terms |
Prostatic Neoplasms- Prostatic Neoplasms
- Prostate Neoplasms
- Neoplasms, Prostate
- Neoplasm, Prostate
- Prostate Neoplasm
- Neoplasms, Prostatic
- Neoplasm, Prostatic
- Prostatic Neoplasm
Prostate Cancer- Prostate Cancer
- Cancer, Prostate
- Cancers, Prostate
- Prostate Cancers
- Cancer of the Prostate
- Prostatic Cancer
- Cancer, Prostatic
- Cancers, Prostatic
- Prostatic Cancers
- Cancer of Prostate
|
Below are MeSH descriptors whose meaning is more general than "Prostatic Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Prostatic Neoplasms".
This graph shows the total number of publications written about "Prostatic Neoplasms" by people in this website by year, and whether "Prostatic Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 2 | 0 | 2 |
| 1996 | 1 | 0 | 1 |
| 1997 | 1 | 0 | 1 |
| 1998 | 1 | 0 | 1 |
| 1999 | 0 | 1 | 1 |
| 2000 | 1 | 0 | 1 |
| 2002 | 0 | 2 | 2 |
| 2003 | 3 | 0 | 3 |
| 2005 | 4 | 0 | 4 |
| 2006 | 3 | 0 | 3 |
| 2007 | 3 | 1 | 4 |
| 2009 | 2 | 0 | 2 |
| 2010 | 2 | 3 | 5 |
| 2011 | 1 | 1 | 2 |
| 2012 | 4 | 0 | 4 |
| 2013 | 4 | 0 | 4 |
| 2014 | 5 | 1 | 6 |
| 2015 | 4 | 1 | 5 |
| 2016 | 4 | 0 | 4 |
| 2017 | 5 | 0 | 5 |
| 2018 | 3 | 1 | 4 |
| 2019 | 2 | 1 | 3 |
| 2020 | 2 | 0 | 2 |
| 2021 | 6 | 0 | 6 |
| 2022 | 3 | 0 | 3 |
| 2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Prostatic Neoplasms" by people in Profiles.
-
Single-Port Robot-Assisted Radical Prostatectomy: Where Do We Stand? Curr Oncol. 2023 04 20; 30(4):4301-4310.
-
Enzalutamide Monotherapy vs Active Surveillance in Patients With Low-risk or Intermediate-risk Localized Prostate Cancer: The ENACT Randomized Clinical Trial. JAMA Oncol. 2022 08 01; 8(8):1128-1136.
-
Multi-institutional analysis of clinical and imaging risk factors for detecting clinically significant prostate cancer in men with PI-RADS 3 lesions. Cancer. 2022 09 15; 128(18):3287-3296.
-
Pro: Magnetic Resonance Imaging Targeting Leads to Overtreatment of Prostate Cancer. J Urol. 2022 08; 208(2):246-247.
-
Outcomes of freehand transperineal prostate biopsy with omission of antibiotic prophylaxis. BJU Int. 2022 07; 130(1):54-61.
-
Assessing the diagnostic performance of systematic freehand PrecisionPoint transperineal prostate biopsy: Comparison of observed outcomes to PBCG nomogram predictions. Urol Oncol. 2022 01; 40(1):4.e9-4.e17.
-
Incidental Diagnosis of Metastatic Prostate Cancer Post-Inguinal Hernia Repair. Am Surg. 2022 Mar; 88(3):552-553.
-
Comparative analysis of 1152 African-American and European-American men with prostate cancer identifies distinct genomic and immunological differences. Commun Biol. 2021 06 03; 4(1):670.
-
Re: Oral Relugolix for Androgen-deprivation Therapy in Advanced Prostate Cancer. Eur Urol. 2021 09; 80(3):386.
-
Impact of Hormonal Therapies for Treatment of Hormone-Dependent Cancers (Breast and Prostate) on the Cardiovascular System: Effects and Modifications: A Scientific Statement From the American Heart Association. Circ Genom Precis Med. 2021 06; 14(3):e000082.